| Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ... Journal of Thoracic Oncology 5 (10), 1706-1713, 2010 | 358 | 2010 |
| Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma MJ Fernández‐Aceñero, M Galindo‐Gallego, J Sanz, A Aljama Cancer 88 (7), 1544-1548, 2000 | 226 | 2000 |
| Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior B Perez Villamil, A Romera Lopez, S Hernandez Prieto, G Lopez Campos, ... BMC cancer 12, 1-13, 2012 | 146 | 2012 |
| Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer JS Ortega, SM Steinberg, E Moro, M Saez, JA Lopez, E Sierra, ... Histology and histopathology 15 (2), 455-462, 2000 | 142 | 2000 |
| Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome J Sanz-Ortega, C Vocke, P Stratton, WM Linehan, MJ Merino The American journal of surgical pathology 37 (1), 74-80, 2013 | 138 | 2013 |
| Serrated polyps of the colon: how reproducible is their classification? A Ensari, B Bilezikçi, F Carneiro, GB Doğusoy, A Driessen, A Dursun, ... Virchows Archiv 461, 495-504, 2012 | 88 | 2012 |
| Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of … P Garrido, E Conde, J De Castro, JJ Gómez-Román, E Felip, L Pijuan, ... Clinical and Translational Oncology 22, 989-1003, 2020 | 83 | 2020 |
| Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and … E Conde, A Suarez-Gauthier, A Benito, P Garrido, R García-Campelo, ... PLoS One 9 (9), e107200, 2014 | 80 | 2014 |
| Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging JA García-Saenz, P Ayllón, M Laig, D Acosta-Eyzaguirre, ... BMC cancer 17, 1-8, 2017 | 76 | 2017 |
| Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II J Ruiz, A Martínez, S Hernández, H Zimman, M Ferrer, C Fernández, ... Histology and histopathology, 2010 | 64 | 2010 |
| Prognostic influence of p53 nuclear overexpression in colorectal carcinoma MG Gallego, MJF Aceñero, SJ Ortega, AA Delgado, JLB Cantero Diseases of the colon & rectum 43 (7), 971-975, 2000 | 64 | 2000 |
| Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non–small cell lung carcinoma: the ROSING study E Conde, S Hernandez, R Martinez, B Angulo, J De Castro, ... Journal of Thoracic Oncology 14 (12), 2120-2132, 2019 | 63 | 2019 |
| Hepatocellular carcinomas diagnosed following metastasis to the oral cavity. Report of 2 cases F Llanes, J Sanz‐Ortega, B Suarez, J Sanz‐Esponera Journal of periodontology 67 (7), 717-719, 1996 | 61 | 1996 |
| Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer T Caldés, J Godino, A Sanchez, C Corbacho, M De la Hoya, ... Oncology reports 12 (3), 621-629, 2004 | 60 | 2004 |
| Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain T Caldes, J Godino, M de la Hoya, I Garcia Carbonero, P Perez Segura, ... International journal of cancer 98 (5), 774-779, 2002 | 59 | 2002 |
| Impact of frailty and disability on 30-day mortality in older patients with acute heart failure FJ Martín-Sánchez, E Rodríguez-Adrada, MT Vidan, GL García, ... The American journal of cardiology 120 (7), 1151-1157, 2017 | 55 | 2017 |
| Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas RF Chuaqui, J Sanz-Ortega, C Vocke, WM Linehan, J Sanz-Esponera, ... Cancer research 55 (21), 4995-4998, 1995 | 55 | 1995 |
| 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary F Losa, L Iglesias, M Pané, J Sanz, B Nieto, V Fusté, L de la Cruz-Merino, ... Clinical and Translational Oncology 20, 1361-1372, 2018 | 51 | 2018 |
| Vascular enumeration as a prognosticator for colorectal carcinoma MG Gallego, MJF Aceñero, JS Ortega, A Aljama European Journal of Cancer 36 (1), 55-60, 2000 | 51 | 2000 |
| LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions: prognostic implications J Sanz-Ortega, J Sanz-Esponera, T Caldes, EG De La Concha, ME Sobel, ... Pathology-Research and Practice 192 (12), 1206-1210, 1996 | 48 | 1996 |
